For decades, a Huntington’s disease diagnosis has been a death sentence. However, after years of work and numerous failed trials, researchers may have finally developed a viable treatment. In clinical trial results released on September 24, a gene therapy called AMT-130 became the first treatment actually to slow the progression of Huntington’s disease. The First Actual Treatment for Huntington’s Disease Might Finally Be HereAMT-130 is a gene therapy. In the 17 patients given a high dose and tracked over three years, progression slowed by 75 percent compared to those on standard treatment.